Ariana is a leading decision support company, focused on transforming data into information to accelerate the discovery and development process and to improve the safety of pharmaceutical drugs.
The Company, based in central Paris, is a spin off of the Institut Pasteur. It was launched in 2003.
It has already established a rapidly growing and profitable software business through collaboration and licensing agreements with some of the largest pharmaceutical and biotechnology companies.
Ariana has developed KEM® (Knowledge Management and Extraction), a proprietary decision support technology for rapid analysis of multi-parametric / multi-objective data.
Discovery: Deployed in pharmaceutical companies, KEM® has a unique ability to translate analysis of data from multiple sources into successful decisions for the optimization of novel drug therapies.
Clinical Trials: KEM® can fully characterize populations that are most responsive and populations at risk, optimizing the design and radically improving the outcome of the trial as well as focusing the post launch marketing effort.
Safety: Early Signal Detection. KEM® provides an exhaustive hypotheses generation platform. Unbiased logic based evaluation of relations between Adverse Events and products leads to key drivers for Safety Reports, Safety Specifications and Risk Minimization Action Plans.
